Literature DB >> 16641209

Hepatoma-derived growth factor is expressed after vascular injury in the rat and stimulates smooth muscle cell migration.

Jill V Narron1, Tamara D Stoops, Kurt Barringhaus, Martin Matsumura, Allen D Everett.   

Abstract

The role of hepatoma-derived growth factor (HDGF), a novel nuclear-targeted vascular smooth muscle cell (SMC) mitogen in vascular injury is unknown. We hypothesized that HDGF plays a role in SMC proliferation and migration in formation of the neointima after balloon injury of the rat carotid. Using co-immunohistochemical staining, HDGF and proliferating cell nuclear antigen (PCNA) were co-expressed in 80% of nuclei of neointimal cells 7 d post carotid balloon injury with HDGF. The HDGF-positive medial and neointimal cells were smooth muscle actin negative and therefore likely represented a subgroup of SMC that have undergone phenotypic switching. Utilizing modified Boyden chamber migration assays, adenoviral-expressed HDGF in mouse SMC increased migration 10-fold (20 versus 2). HDGF gene silencing reduced both SMC proliferation and migration. In conclusion, HDGF is highly expressed in the media and neointima post balloon injury, a SMC mitogen and positive regulator of cell migration. We speculate that HDGF is involved in the SMC proliferative and migratory response to injury resulting in neointimal formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641209     DOI: 10.1203/01.pdr.0000219299.24435.4f

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  14 in total

1.  Mechanical behavior and matrisome gene expression in the aneurysm-prone thoracic aorta of newborn lysyl oxidase knockout mice.

Authors:  Marius Catalin Staiculescu; Jungsil Kim; Robert P Mecham; Jessica E Wagenseil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-05-26       Impact factor: 4.733

2.  Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor.

Authors:  Fei Liao; Weiguo Dong; Lifang Fan
Journal:  Med Oncol       Date:  2009-11-19       Impact factor: 3.064

3.  The proteasome inhibitor lactacystin attenuates growth and migration of vascular smooth muscle cells and limits the response to arterial injury.

Authors:  Kurt G Barringhaus; Martin E Matsumura
Journal:  Exp Clin Cardiol       Date:  2007

4.  The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.

Authors:  Siang-Yo Lin; Jun Yang; Allen D Everett; Charles V Clevenger; Mythili Koneru; Pravin J Mishra; Barton Kamen; Debabrata Banerjee; John Glod
Journal:  Exp Cell Res       Date:  2008-08-08       Impact factor: 3.905

5.  Mitotic phosphorylation activates hepatoma-derived growth factor as a mitogen.

Authors:  Allen D Everett; Jun Yang; Monzur Rahman; Pratima Dulloor; David L Brautigan
Journal:  BMC Cell Biol       Date:  2011-04-13       Impact factor: 4.241

6.  Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation.

Authors:  Angela Sedlmaier; Nicolas Wernert; Rainer Gallitzendörfer; Mekky M Abouzied; Volkmar Gieselmann; Sebastian Franken
Journal:  BMC Cancer       Date:  2011-10-20       Impact factor: 4.430

7.  Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.

Authors:  Jun Yang; Melanie K Nies; Zongming Fu; Rachel Damico; Frederick K Korley; Paul M Hassoun; David D Ivy; Eric D Austin; Allen D Everett
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

8.  Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain.

Authors:  Jun Yang; Allen D Everett
Journal:  BMC Mol Biol       Date:  2007-10-31       Impact factor: 2.946

9.  Hepatoma-derived growth factor and its role in keloid pathogenesis.

Authors:  B N S Ooi; A Mukhopadhyay; J Masilamani; D V Do; C P Lim; X M Cao; I J Lim; L Mao; H N Ren; H Nakamura; T T Phan
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310

10.  Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas.

Authors:  Yang Yang; Shengru Liang; Yuqian Li; Fei Gao; Longlong Zheng; Shilai Tian; Pu Yang; Lihong Li
Journal:  Oncol Lett       Date:  2017-10-13       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.